Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Withdrawn 3Terminated 2Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Kidney Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Cyclophosphamide 390Carboplatin 343Gemcitabine 331pembrolizumab 330Cisplatin 327Paclitaxel 295Radiotherapy 292Docetaxel 286Bevacizumab 249Rituximab 233Capecitabine 222Nivolumab 220Dexamethasone 205Fluorouracil 189fludarabine 178Oxaliplatin 177Pemetrexed 153Doxorubicin 152Irinotecan 147Etoposide 144Leucovorin 143Cytarabine 134fludarabine phosphate 129Bortezomib 129Cetuximab 127Lenalidomide 125Filgrastim 120Erlotinib Hydrochloride 119Temozolomide 111Ipilimumab 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Interventional × AH 111585 × Clear all
NCT01492192 2017-11-01

RGD-PET-CT in Cancer Angiogenesis

Oxford University Hospitals NHS Trust

Phase 2 Terminated
10 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT01961583 2016-03-01

[18F]Fluciclatide PET Imaging of Pazopanib Response

Asan Medical Center

Phase 2 Terminated
12 enrolled
Genitourinary

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡